Cargando…
Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619496/ https://www.ncbi.nlm.nih.gov/pubmed/34834264 http://dx.doi.org/10.3390/pharmaceutics13111852 |
_version_ | 1784605006650933248 |
---|---|
author | Varga-Medveczky, Zsófia Kocsis, Dorottya Naszlady, Márton Bese Fónagy, Katalin Erdő, Franciska |
author_facet | Varga-Medveczky, Zsófia Kocsis, Dorottya Naszlady, Márton Bese Fónagy, Katalin Erdő, Franciska |
author_sort | Varga-Medveczky, Zsófia |
collection | PubMed |
description | During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusion measurements, different devices, and diffusion platforms used, are summarized in the introductory part of this review. Then the methodologies applied at Pázmány Péter Catholic University are shown in detail. The main testing platforms (Franz diffusion cells, skin-on-a-chip devices) and the major scientific projects (P-glycoprotein interaction in the skin; new skin equivalents for diffusion purposes) are also presented in one section. The main achievements of our research are briefly summarized: (1) new skin-on-a-chip microfluidic devices were validated as tools for drug penetration studies for the skin; (2) P-glycoprotein transport has an absorptive orientation in the skin; (3) skin samples cannot be used for transporter interaction studies after freezing and thawing; (4) penetration of hydrophilic model drugs is lower in aged than in young skin; (5) mechanical sensitization is needed for excised rodent and pig skins for drug absorption measurements. Our validated skin-on-a-chip platform is available for other research groups to use for testing and for utilizing it for different purposes. |
format | Online Article Text |
id | pubmed-8619496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86194962021-11-27 Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments Varga-Medveczky, Zsófia Kocsis, Dorottya Naszlady, Márton Bese Fónagy, Katalin Erdő, Franciska Pharmaceutics Review During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusion measurements, different devices, and diffusion platforms used, are summarized in the introductory part of this review. Then the methodologies applied at Pázmány Péter Catholic University are shown in detail. The main testing platforms (Franz diffusion cells, skin-on-a-chip devices) and the major scientific projects (P-glycoprotein interaction in the skin; new skin equivalents for diffusion purposes) are also presented in one section. The main achievements of our research are briefly summarized: (1) new skin-on-a-chip microfluidic devices were validated as tools for drug penetration studies for the skin; (2) P-glycoprotein transport has an absorptive orientation in the skin; (3) skin samples cannot be used for transporter interaction studies after freezing and thawing; (4) penetration of hydrophilic model drugs is lower in aged than in young skin; (5) mechanical sensitization is needed for excised rodent and pig skins for drug absorption measurements. Our validated skin-on-a-chip platform is available for other research groups to use for testing and for utilizing it for different purposes. MDPI 2021-11-03 /pmc/articles/PMC8619496/ /pubmed/34834264 http://dx.doi.org/10.3390/pharmaceutics13111852 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Varga-Medveczky, Zsófia Kocsis, Dorottya Naszlady, Márton Bese Fónagy, Katalin Erdő, Franciska Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments |
title | Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments |
title_full | Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments |
title_fullStr | Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments |
title_full_unstemmed | Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments |
title_short | Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments |
title_sort | skin-on-a-chip technology for testing transdermal drug delivery—starting points and recent developments |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619496/ https://www.ncbi.nlm.nih.gov/pubmed/34834264 http://dx.doi.org/10.3390/pharmaceutics13111852 |
work_keys_str_mv | AT vargamedveczkyzsofia skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments AT kocsisdorottya skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments AT naszladymartonbese skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments AT fonagykatalin skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments AT erdofranciska skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments |